Aclaris Therapeutics, Inc.ACRSNASDAQ
Loading
Profit from core business operations before interest and taxes
Latest
$-76.38M
↑ 16% vs avg
Percentile
P50
Within normal range
Streak
1 yr
Consecutive growthExpanding
Average
$-91.36M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $-76.38M | +46.2% |
| 2024 | $-141.93M | -45.8% |
| 2023 | $-97.36M | -8.4% |
| 2022 | $-89.85M | -0.1% |
| 2021 | $-89.72M | -76.2% |
| 2020 | $-50.91M | +54.2% |
| 2019 | $-111.06M | +18.0% |
| 2018 | $-135.41M | -87.0% |
| 2017 | $-72.42M | -49.1% |
| 2016 | $-48.57M | - |